Parathyroid hormone formulation
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 5, 1996
Grant Date -
N/A
app pub date -
Dec 23, 1993
filing date -
Dec 23, 1993
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Described herein are preparations containing parathyroid hormone that has been stablized with an excipient and buffering agent. Preferred preparations incorporate human PTH(1-84), mannitol as excipient and citrate as buffering agent, and are incorporated in vials as a freeze-dried powder for reconstitution to treat osteoporosis.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully